Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sinn

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
ESMO Open|August 21, 2022
Multimodal survival prediction in advanced pancreatic cancer using machine learningJ Keyl, S Kasper, M Wiesweg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Ebiomedicine|April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trialK Hoyer, R Hablesreiter, Y Inoue, et al.
ESMO Open|February 5, 2022
Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 studyS F Kruger, A Lohneis, A Abendroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE studyF Lordick, M E Mauer, G Stocker, et al.
Zeitschrift Fur Gastroenterologie|February 11, 2022
M Bitzer, S Voesch, J Albert, et al.
Zeitschrift Fur Gastroenterologie|February 11, 2022
M Bitzer, S Voesch, J Albert, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2014
SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
ESMO Open|August 21, 2022
Multimodal survival prediction in advanced pancreatic cancer using machine learningJ Keyl, S Kasper, M Wiesweg, et al.
European Journal of Cancer (Oxford, England : 1990)|September 5, 2020
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final resultsM Sinn, T Liersch, H Riess, et al.
Ebiomedicine|April 16, 2021
A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trialK Hoyer, R Hablesreiter, Y Inoue, et al.
ESMO Open|February 5, 2022
Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 studyS F Kruger, A Lohneis, A Abendroth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE studyF Lordick, M E Mauer, G Stocker, et al.
Zeitschrift Fur Gastroenterologie|February 11, 2022
M Bitzer, S Voesch, J Albert, et al.
Zeitschrift Fur Gastroenterologie|February 11, 2022
M Bitzer, S Voesch, J Albert, et al.
Pageof 4